2 news items
Ligand Pharmaceuticals Announces New Topiramate Injection Data Presented at 9th London-Innsbruck Colloquium on Status Epilepticus and Acute Seizures Conference
LGND
8 Apr 24
of excellence. We are proud of our land-grant mission of world-class education, groundbreaking research, and community-engaged outreach, and we are unified
Ligand Reports Fourth Quarter and Full Year 2023 Financial Results
ALDX
LGND
MRK
27 Feb 24
. Accelerated Approval of FILSPARI to full approval. Travere also completed regulatory engagement on focal segmental glomerulosclerosis (FSGS) in which
- Prev
- 1
- Next